Oxford Immunotec Global PLC (NASDAQ:OXFD) has scheduled a conference call for 3rd November 2020 at 8:00 AM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.oxfordimmunotec.com
Earnings Expectation
Oxford Immunotec Global PLC is expected to report third quarter earnings results, before market open, on Tuesday 3rd November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.05 per share from revenue of $ 18.65 million. Looking ahead, the full year loss are expected at $ 0.67 per share on the revenues of $ 57.03 million.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 18.00 million ~ $ 19.00 million
Full Year 2020 topline are forecasted in a range of$ 78.00 million ~ $ 81.00 million
Click Here For More Historical Outlooks Of Oxford Immunotec Global PLC
Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States. It develops its products using its T-SPOT technology platform, which enables the measurement of responses of specific immune cells to inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. The company develops and markets T-SPOT.TB test used to test for tuberculosis.
